13F filer · CIK 1278387
BROADWOOD CAPITAL INC
New York, NY · filing since Q2 2013 · last filing Aug 14, 2026
Reported value
$1.9B
+$494.4M vs prior
Positions
6
New / sold out
0 / 0
Added / reduced
1 / 0
Turnover
0.0%
buys $4.4M · sells $0
Top-10 weight
100.0%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | INSIGHT MOLECULAR DIA INC | +753,045 | +6.3% | +$4.4M |
Biggest sells vs Q1 2026
No reduced or sold positions this quarter.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | MONSTER BEVERAGE CORP NEWCOM | 8,107,796 | $779.3M | 40.73% |
| 2 | STAAR SURGICAL COCOM PAR $0.01 | 16,123,842 | $462.6M | 24.18% |
| 3 | AXON ENTERPRISE INCCOM | 693,504 | $388.8M | 20.32% |
| 4 | ISHARES TRRUSSELL 2000 ETF | 474,920 | $142.7M | 7.46% |
| 5 | INSIGHT MOLECULAR DIA INCCOM NEW | 12,684,884 | $74.8M | 3.91% |
| 6 | LINEAGE CELL THERAPEUTICS INCOM | 49,560,992 | $64.9M | 3.39% |